Legend Holdings, Eli Lilly, Ping An, China Life and Taikang-backed Innovent Biologics priced its shares near the top of the range of to raise $421m.

Innovent Biologics, a China-based biopharmaceutical company that counts corporates China Life, Eli Lilly, Legend Holdings, Ping An and Taikang as investors, is raising $421m in its initial public offering, Reuters reported today. The company is issuing 236 million shares priced at HK$13.98 ($1.78) each, near the top of theĀ $1.60 to $1.80m range the company had…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.